Norton Rose, Latham Steer Alcon's $430M Lensar Buy
By Jade Martinez-Pogue · March 24, 2025, 4:50 PM EDT
Eye care company Alcon, advised by Norton Rose Fulbright, unveiled on Monday an agreement to purchase medical technology developer Lensar, which is represented by Latham & Watkins LLP, for up to $430 million....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login